Healixia News - page 2

October 23, 2023

Healixia Clinical Conference 2023

On Thursday October 19^th 2023, we held our yearly Healixia Clinical Conference at Frame21 in Zaventem. We look back at another amazing edition with inspiring talks and interactions, approaching clinical research from different perspectives with one common goal: helping patients.

October 5, 2023

IFAPP Today newsletter - October 2023

Source: IFAPP

Please find here the link to the IFAPP TODAY newsletter of October 2023.

September 20, 2023

Energizing Strategic meeting!

On September 14^th, our board & education group members gathered for our yearly strategic meeting, discussing Healixia’s vision, focus and future actions.

September 14, 2023

The QbD Group acquires life sciences consultancy Azierta

Azierta, a life sciences and health consultancy located in Madrid and counting 70 multi-skilled employees, has joined the QbD Group.

Source: QbD

September 7, 2023

Customs and the FAMHP seize 1.5 tonnes of illegal medicines

On 14 July 2023, customs and the FAMHP seized 1.5 tonnes of illegal medicines at Brucargo. This is one of the largest seizures in the European Union in recent years.

Source: FAMHP

September 7, 2023

IFAPP Today newsletter - September 2023

Source: IFAPP

Please find here the link to the IFAPP TODAY newsletter of September 2023.

August 17, 2023

IN MEMORIAM Noël Wathion

Just over a year ago, we were honored to hand over to Noël Wathion the first Healixia award for his outstanding contribution to the pharmaceutical landscape. Today, we unfortunately have to say goodbye to this inspiring man.

July 24, 2023

IFAPP Today newsletter - July/August 2023

Source: IFAPP

Please find here the link to the IFAPP TODAY newsletter of July/August 2023.

July 17, 2023

Unavailability of Hydrea 500 mg hard caps. 20: derogation and strategic stock

In het kader van de onbeschikbaarheid van het geneesmiddel Hydrea 500 mg harde caps. 20 werd een strategische stock aangekocht door de overheid. Een deel van deze strategische stock is vanaf 13 juli 2023 beschikbaar voor distributie. Volgende leveringen worden nog verwacht in de volgende weken.

Dans le cadre de l'indisponibilité du médicament Hydrea 500 mg x 20 gélules, un stock stratégique a été acheté par le gouvernement. Une partie de ce stock stratégique est disponible pour distribution à partir du 13 juillet 2023. Des livraisons ultérieures sont encore attendues dans les semaines suivantes.

Source: FAMHP

July 13, 2023

Quality Innovation Group - Listen and Learn Focus Group hybrid meeting -12 & 13 October 2023 - Call for Abstract

The Quality Innovation Group (QIG) has been established by the EU Regulatory Network with the aim of supporting the translation of innovative approaches for the development, manufacture and quality control of medicines to the benefit of patients. These include, but are not limited to, innovative technologies, digitalization, novel materials and novel devices, in line with network priorities highlighted in the EMA Regulatory Science Strategy to 2025. Further details on QIG can be found on the group webpage and on the related press release.

Source: Quality Innovation Group